Listed by the USPTO as NGO, MEAGAN N
Tech Center 3700 • Art Units: 3781
This examiner grants 59% of resolved cases
NGO, MEAGAN N is a USPTO patent examiner in Tech Center 3700 and Art Unit 3781. The profile records 224 resolved cases and a 58.9% allowance rate. The rate indicates that allowance is less frequent in the observed record than denial or other non-allowance outcomes, making early claim assessment and careful prosecution positioning especially important.
The interview lift is 32.1%, a substantial reported association that supports considering examiner interviews as part of a coordinated response strategy. The median time to allowance is 1294 days, so applicants should prepare clients for extended prosecution and protect timing-sensitive objectives. The listed companies are 3M Company, The Procter & Gamble Company, and Baxter Healthcare S.A. The listed firms are K&L Gates LLP-Chicago, BIRCH STEWART KOLASCH & BIRCH, LLP, and Bookoff McAndrews, PLLC.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18960162 | ABSORBENT ARTICLE WITH EAR PORTION | Non-Final OA | The Procter & Gamble Company |
| 18663455 | ABSORBENT ARTICLE | Final Rejection | The Procter & Gamble Company |
| 18215973 | TISSUE RESECTION SYSTEMS INCLUDING FLUID OUTFLOW MANAGEMENT | Non-Final OA | Covidien LP |
| 18852963 | METHOD AND SYSTEM FOR MONITORING A WASTE STREAM TO INCREASE EFFICIENCY OF A SURGICAL IRRIGATION PROCEDURE | Non-Final OA | CareFusion 2200, Inc. |
| 18840808 | APPARATUS AND SYSTEM FOR MANAGING TUBING AT A TISSUE SITE | Non-Final OA | Solventum Intellectual Properties Company |
| 18216376 | CONTOURED FOAM DRESSING SHAPED FOR PROVIDING NEGATIVE PRESSURE TO INCISIONS IN THE BREAST | Non-Final OA | Solventum Intellectual Properties Company |
| 18018738 | BIORESORBABLE DRESSING FOR NEGATIVE-PRESSURE THERAPY | Non-Final OA | Solventum Intellectual Properties Company |
| 18251878 | BLOOD TRANSFER SHIELD AND METHODS OF USE | Final Rejection | The General Hospital Corporation |
| 18179941 | MULTI-ARTICULATED CATHETERS WITH SAFETY METHODS AND SYSTEMS FOR IMAGE-GUIDED COLLABORATIVE INTRAVASCULAR DEPLOYMENT | Non-Final OA | Vanderbilt University |
| 18456456 | SENSOR APPARATUS SYSTEMS, DEVICES AND METHODS | Non-Final OA | DEKA Products Limited Partnership |
| 18936047 | DELIVERY AIDS FOR GLAUCOMA SHUNTS | Non-Final OA | W. L. Gore & Associates, Inc. |
| 18839933 | SYRINGE FOR CRYOPRESERVATION | Non-Final OA | OTSUKA PHARMACEUTICAL FACTORY, INC. |
| 18994079 | OSTOMY APPLIANCE WITH ADHESIVE HAVING TROUGH AND CREST PORTIONS | Non-Final OA | Coloplast A/S |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy58.9% of resolved applications examined by Meagan N Ngo were allowed (224 resolved cases), compared with 50.8% across Art Unit 3781 over the last five years.
This examiner's interview lift is +32.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Meagan N Ngo took 1,294 days on average from filing to allowance.
Meagan N Ngo examines applications in Art Unit 3781 in Tech Center 3700 (Medical Devices & Mechanical Engineering).